FDA Approves Pancreatic Enzyme Products to Aid Digestion

02 Mar 2012 --- Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Mar 2 2012 --- Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved by the U.S. Food and Drug Administration.

Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Viokace, in combination with a proton pump inhibitor, is used to treat adults who cannot digest food normally. Adults with chronic pancreatitis, a continuing, chronic inflammatory process of the pancreas, or those who have had some or all of their pancreases removed (pancreatectomy) may not digest food normally because they lack needed enzymes or because their enzymes are not released into the bowel (intestine). Viokace’s safety and efficacy in children has not been established.

“The approvals of Ultresa and Viokace, along with the other approved pancreatic enzyme products, allow health care providers to prescribe the product that is most appropriate for the estimated 200,000 patients in the United States who have pancreatic insufficiency,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA’s Center for Drug Evaluation and Research.

Ultresa and Viokace are the fourth and fifth pancreatic enzyme products approved by FDA. Other FDA-approved pancreatic enzyme products include Creon (2009), Zenpep (2009) and Pancreaze (2010). Approved pancreatic enzyme products meet FDA standards for safety, efficacy and product quality.

Unapproved pancreatic enzyme products had been available for many years. FDA established a date of April 28, 2010 for the makers of pancreatic enzyme products to stop manufacturing and distributing unapproved products.

Ultresa and Viokace are marketed by Bridgewater, N.J.-based Aptalis Pharma U.S. Inc.
 

Related Articles

Health & Nutrition News

Study Suggests Link Between Breastfeeding And Success Later In Life

27 Jul 2015 --- The Nestle Nutrition Institute has shared the results of a study that concludes that infants who are breastfed become more successful adults.

Health & Nutrition News

Research: Rice Disease-Resistance Discovery Closes the Loop for Scientific Integrity

27 Jul 2015 --- When disease-resistant rice is invaded by disease-causing bacteria, a small protein produced by the bacteria betrays the invader. Upon recognizing that protein, the rice plants sense that a microbial attack is underway and are able to mount an immune response to fend off bacterial infection, reports a research team led by the University of California, Davis.

Health & Nutrition News

Nutrient Density Can Break the Malnutrition and Obesity Cycle

24 Jul 2015 --- DSM’s new article, which suggests that nutrient density can be used as a tool to help break the intergenerational cycle of malnutrition and obesity, has been published in the human nutrition journal Nutrients. The paper follows a workshop held at the University Medical Center in Groningen, where experts discussed the nutritional situation of the general population and the role that diet plays during critical periods of life, when the body is most susceptible to changes that increase the risk of developing non-communicable diseases (NCDs).

Health & Nutrition News

Lower Calorie Intake and Exercise May Reduce Diabetes Risk

24 Jul 2015 --- American researchers from Saint Louis University in St. Louis, Washington University School of Medicine in St. Louis, and Baylor College of Medicine in Houston, have concluded that, in sedentary, overweight women and men, the combination of calorie restriction (eating fewer calories than normally consumed) and exercise has additive effects on the regulation of blood sugar levels after a meal.

More Articles
URL : http://www.nutritioninsight.com:80/news/FDA-Approves-Pancreatic-Enzyme-Products-to-Aid-Digestion.html